{"disease":{"id":"high-grade-salivary-gland-carcinoma","name":"high grade salivary gland carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05727410","title":"Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Myung-Ju Ahn","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}